lobbying_activities: 3385166

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3385166	4317558b-70e1-4e85-9fec-fbcfbb02b197	Q2	INVARIANT LLC	314237	SK AMERICAS, INC.	2025	second_quarter	PHA	Monitor proposals and issues related to biopharmaceuticals. Educate policymakers on SK Pharmteco's active pharmaceutical ingredient manufacturing capabilities.	Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE	140000		0	0	2025-07-16T13:37:01-04:00